Douglas Insights

The major factors impeding the expansion of the global achondroplasia market are the adverse effects and high price of drugs used to treat achondroplasia.

DOUGLAS, ISLE OF MAN, January 9, 2023 /EINPresswire.com/ -- Achondroplasia Therapeutics Market Analysis

The achondroplasia therapeutics market is expected to grow at a CAGR of 7.2% over the forecast period (2022–2028). The growth is mainly attributed to the increasing incidence of the disease and the rise in investment in the development of new achondroplasia therapies.

Achondroplasia is a genetic disorder that affects the protein fibroblast growth factor receptor. In achondroplasia, this protein begins to function abnormally, slowing bone development in the growth plate cartilage. Adults with achondroplasia range in height from 42 to 56 inches. The genetic disorder is transmissible from parent to child. However, in approximately 80% of cases, achondroplasia is caused by a spontaneous mutation (a sudden genetic defect) that originates during embryonic development.

A full report with detailed analysis and figures is available at: https://douglasinsights.com/achondroplasia-therapeutics-market

Achondroplasia Therapeutics Market Growth: Drivers and Risks

The increasing approvals and launches of new drugs by the market's leading players are anticipated to drive market expansion. As an example, on January 13, 2022, Ascendis Pharma A/S, a biopharmaceutical company based in Denmark, announced that the European Commission (EC) had approved TransCon hGH as a once-weekly subcutaneous injection for the treatment of pediatric patients experiencing growth failure due to insufficient endogenous growth hormone secretion or a deficiency of growth hormone. TransCon hGH contains somatropin, which delivers therapeutic quantities of unmodified somatropin (hGH) to the body.

The major factors impeding the expansion of the global achondroplasia market are the adverse effects and high price of drugs used to treat achondroplasia. For example, growth hormone treatment can be costly, costing between $10,000 and $60,000 per year for growth hormone treatment alone. In addition, the list price of VOXZOGO (vosoritide) in France under the ATU (Temporary Authorization for Use) process is 712 euros (837.3 dollars) per vial.

Players in the Achondroplasia Therapeutics Market

The key players in this market are Teva Pharmaceuticals, Novartis AG, Pfizer Inc., AstraZeneca Plc, and Eli Lilly.

Achondroplasia Therapeutics Market Segmentation

By Treatment Type

• Growth hormone therapy
• Surgery
• Supportive Therapy

By End-User

• Hospitals
• Specialty Clinics
• Retail Pharmacies
• Others

Table of Content-

1 . PREFACE
1.1. Report Description
1.1.1. Objective
1.1.2. Target Audience
1.1.3. Unique Selling Proposition (USP) & offerings
1.2. Research Scope
1.3. Research Methodology
1.3.1. Market Research Process
1.3.2. Market Research Methodology

2 . EXECUTIVE SUMMARY
2.1. Highlights of Achondroplasia Therapeutics Market
2.2. Global Achondroplasia Therapeutics Market Snapshot

3 . ACHONDROPLASIA THERAPEUTICS – INDUSTRY ANALYSIS
3.1. Introduction
3.2. Market Drivers of Achondroplasia Therapeutics Market
3.3. Market Restraints of Achondroplasia Therapeutics Market
3.4. Opportunities of Achondroplasia Therapeutics Market
3.5. Trends of Achondroplasia Therapeutics Market
3.6. Porter’s Five Force Analysis of Achondroplasia Therapeutics Market
3.7. Achondroplasia Therapeutics Market Attractiveness Analysis
3.7.1 Market Attractive Analysis by Treatment Type
3.7.2 Market Attractive Analysis by End-User
3.7.3 Market Attractive Analysis by Region

4 . VALUE CHAIN ANALYSIS
4.1. Achondroplasia Therapeutics Value Chain Analysis
4.2. Achondroplasia Therapeutics Raw Material Analysis
4.2.1. List of Raw Materials
4.2.2. Achondroplasia Therapeutics Raw Material Manufactures List
4.2.3. Price Trend of Achondroplasia Therapeutics Key Raw Materials
4.3. List of Potential Buyers
4.4. Marketing Channel
4.4.1. Direct Marketing
4.4.2. Indirect Marketing
4.4.3. Marketing Channel Development Trend

5 IMPACT ANALYSIS OF COVID-19 OUTBREAK
5.1. Impact Analysis of Covid-19 Outbreak on Achondroplasia Therapeutics Market
5.1.1. Direct Impact on Production
5.1.2. Supply Chain and Market Disruption
5.1.3. Financial Impact on Firms and Financial Markets
5.2. COVID-19 Impact Analysis by Production, Import, Export and Demand
5.3. Achondroplasia Therapeutics Market: Pre V/S Post COVID-19
5.4. Estimated Impact of the Coronavirus (COVID-19) Epidemic on the Achondroplasia Therapeutics Market Size in 2020, by Scenario
5.5. COVID-19: Micro and Macro Factor Analysis on Achondroplasia Therapeutics Market

6 . GLOBAL ACHONDROPLASIA THERAPEUTICS MARKET ANALYSIS BY TREATMENT TYPE
6.1 Overview by Treatment Type
6.2 Historical Data 2015-2018
6.3 Global Achondroplasia Therapeutics Market Analysis by Treatment Type
6.4 Market Analysis of Growth Hormone Therapy by Regions
6.6 Market Analysis of Surgery by Regions
6.5 Market Analysis of Supportive Therapy by Regions

7 . GLOBAL ACHONDROPLASIA THERAPEUTICS MARKET ANALYSIS BY END-USER
7.1 Overview by End-User
7.2 Historical Data 2015-2018
7.3 Global Achondroplasia Therapeutics Market Analysis by End-User
7.4 Market Analysis of Hospitals by Regions
7.5 Market Analysis of Specialty Clinics by Regions
7.6 Market Analysis of Retail Pharmacies by Regions
7.7 Market Analysis of Others by Regions
……toc continued

Access complete report- https://douglasinsights.com/achondroplasia-therapeutics-market

Inquire (for customization, for specific regions, etc.): https://douglasinsights.com/static/contact-us

Follow Douglas Insights for More Industry Updates- @ LinkedIn & Twitter

About Douglas Insights-

Douglas Insights UK limited is the first company to provide comparison of market research reports by Table of content, price, ratings and number of pages. We understand the value of time. Productivity and efficiency are possible when you take prompt and assured decisions. With our advanced algorithm, filters, and comparison engine, you can compare your preferred reports simultaneously, based on publisher rating, published date, price, and list of tables. Our data portal enables you to find and review the reports from several publishers. You can evaluate numerous reports on the same screen and select the sample for your best match.

Office-
Bridge House, W Baldwin Rd,
Isle of Man IM4 5HA, Isle of Man
Email- isabella@douglasinsights.com
Telephone - +44 7624 248772
Web- douglasinsights.com/

Recently Published Reports:

High-Speed Aircraft and Missiles Composite Material Market - https://douglasinsights.com/high-speed-aircraft-and-missiles-composite-material-market
Fluid and Lubricant Market - https://douglasinsights.com/fluid-and-lubricant-market
Biological Control Agent Market - https://douglasinsights.com/biological-control-agent-market
NGS Oncology Market - https://douglasinsights.com/ngs-oncology-market
Digital Biomanufacturing Market - https://douglasinsights.com/digital-biomanufacturing-market

Isabella Hawke
Douglas Insights
+ +44 7624 248772
email us here
Visit us on social media:
Twitter
LinkedIn

Legal Disclaimer:

EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.